If these findings can be replicated in a clinical setting, the TCF7L2 rs7903146T allele may help clinicians identify nondiabetic inpatients at greater risk for accelerated glucose intolerance and hyperglycemia in an inpatient setting. Here, TCF7L2 is linked to Glucose intolerance.